• Profile
Close

Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome

Journal of Autoimmunity Apr 02, 2019

Lee J, et al. - Researchers evaluated the concentration of sialic acid-binding immunoglobulin-like lectin (siglec)-5 in saliva and sera by ELISA to estimate if siglec-5 in saliva could be a biomarker for Primary Sjogren's syndrome (pSS). They observed a significantly higher level of salivary siglec-5 in pSS cases when compared with HCs, non-SS sicca cases or subjects with systemic lupus erythematosus (SLE). They found a negative correlation of salivary siglec-5 level with salivary flow rate whereas positive with an ocular surface score as well as serum immunoglobulin G level.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay